Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$3.74 - $6.63 $62,458 - $110,721
-16,700 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$13.28 - $18.07 $66,400 - $90,350
5,000 Added 42.74%
16,700 $227,000
Q4 2020

Nov 19, 2021

SELL
$16.84 - $27.59 $64,951 - $106,414
-3,857 Reduced 24.79%
11,700 $311,000
Q4 2020

Feb 18, 2021

BUY
$16.84 - $27.59 $64,951 - $106,414
3,857 Added 32.97%
15,557 $414,000
Q3 2020

Nov 13, 2020

BUY
$16.2 - $25.7 $189,540 - $300,690
11,700 New
11,700 $218,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $44.7M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.